Jenny Robertson - Feb 19, 2025 Form 4 Insider Report for Lexeo Therapeutics, Inc. (LXEO)

Role
Chief Legal Officer
Signature
/s/ Youjin Choi, Attorney-in-Fact
Stock symbol
LXEO
Transactions as of
Feb 19, 2025
Transactions value $
-$9,272
Form type
4
Date filed
2/21/2025, 05:08 PM
Previous filing
Jan 10, 2025
Next filing
Apr 9, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXEO Common Stock Sale -$9.27K -2.1K -3.5% $4.41 57.9K Feb 19, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
F2 Includes 54,062 RSUs.